Nilsson S - Search Results

1

ERbeta: a novel estrogen receptor offers the potential for new drug development.

Nilsson S, Kuiper G, Gustafsson JA. Nilsson S, et al. Trends Endocrinol Metab. 1998 Dec;9(10):387-95. doi: 10.1016/s1043-2760(98)00096-4. Trends Endocrinol Metab. 1998. PMID: 18406312

2

Estrogen receptor action.

Nilsson S, Gustafsson JA. Nilsson S, et al. Crit Rev Eukaryot Gene Expr. 2002;12(4):237-57. doi: 10.1615/critreveukaryotgeneexpr.v12.i4.10. Crit Rev Eukaryot Gene Expr. 2002. PMID: 12641394 Review.

3

Selective estrogen receptor modulators and coronary heart disease.

Bian Z, Nilsson S, Gustafsson JA. Bian Z, et al. Among authors: nilsson s. Trends Cardiovasc Med. 2001 Jul;11(5):196-202. doi: 10.1016/s1050-1738(01)00102-5. Trends Cardiovasc Med. 2001. PMID: 11597831 Review.

4

Estrogen receptors: therapies targeted to receptor subtypes.

Nilsson S, Gustafsson JÅ. Nilsson S, et al. Clin Pharmacol Ther. 2011 Jan;89(1):44-55. doi: 10.1038/clpt.2010.226. Epub 2010 Dec 1. Clin Pharmacol Ther. 2011. PMID: 21124311 Review.

5

Molecular mechanisms, physiological consequences and pharmacological implications of estrogen receptor action.

Barkhem T, Nilsson S, Gustafsson JA. Barkhem T, et al. Among authors: nilsson s. Am J Pharmacogenomics. 2004;4(1):19-28. doi: 10.2165/00129785-200404010-00003. Am J Pharmacogenomics. 2004. PMID: 14987119 Review.

6

Development of subtype-selective oestrogen receptor-based therapeutics.

Nilsson S, Koehler KF, Gustafsson JÅ. Nilsson S, et al. Nat Rev Drug Discov. 2011 Sep 16;10(10):778-92. doi: 10.1038/nrd3551. Nat Rev Drug Discov. 2011. PMID: 21921919 Review.

7

Biological role of estrogen and estrogen receptors.

Nilsson S, Gustafsson JA. Nilsson S, et al. Crit Rev Biochem Mol Biol. 2002;37(1):1-28. doi: 10.1080/10409230290771438. Crit Rev Biochem Mol Biol. 2002. PMID: 11905545 Review. No abstract available.

8

pS2 Gene expression in HepG2 cells: complex regulation through crosstalk between the estrogen receptor alpha, an estrogen-responsive element, and the activator protein 1 response element.

Barkhem T, Haldosén LA, Gustafsson JA, Nilsson S. Barkhem T, et al. Among authors: nilsson s. Mol Pharmacol. 2002 Jun;61(6):1273-83. doi: 10.1124/mol.61.6.1273. Mol Pharmacol. 2002. PMID: 12021387

9

Transcriptional synergism on the pS2 gene promoter between a p160 coactivator and estrogen receptor-alpha depends on the coactivator subtype, the type of estrogen response element, and the promoter context.

Barkhem T, Haldosén LA, Gustafsson JA, Nilsson S. Barkhem T, et al. Among authors: nilsson s. Mol Endocrinol. 2002 Nov;16(11):2571-81. doi: 10.1210/me.2002-0051. Mol Endocrinol. 2002. PMID: 12403846

10

Localization of DNase I hypersensitive sites in the human oestrogen receptor gene correlates with the transcriptional activity of two differentially used promoters.

Grandien KF, Berkenstam A, Nilsson S, Gustafsson JA. Grandien KF, et al. Among authors: nilsson s. J Mol Endocrinol. 1993 Jun;10(3):269-77. doi: 10.1677/jme.0.0100269. J Mol Endocrinol. 1993. PMID: 8373511

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,941 results

Search Page

Filters